BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 24, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2004

View Archived Issues

Antibody against collagen IV cryptic epitope limits choroidal neovascularization in vivo

Read More

Improvement of diabetes-induced retinal vascular abnormalities by AGIX-4207

Read More

Rosiglitazone effective in post-transplant diabetes

Read More

Efficacy and safety of pregabalin as add-on therapy for epilepsy

Read More

Pain Therapeutics continues development of three drug candidates

Read More

Serono achieves R&D milestones during first quarter

Read More

New hypusine production inhibitors and their use claimed by Mondobiotech

Read More

New indole-based beta2-adrenoceptor agonists in early development at Pfizer

Read More

Pfizer presents another series of 5-HT4 agonists for GI disorders

Read More

Pfizer scientists identify novel CRTh2 antagonists

Read More

Kansas State U. researchers described inhibitors of lymphatic cholesterol absorption

Read More

Novel estrogen receptor modulators covered by Pfizer patent

Read More

AstraZeneca researchers design novel CCR3 modulators/H1 antagonists

Read More

Evista launched in Japan

Read More

Aquavan enters phase III development

Read More

Abraxane NDA accepted for filing

Read More

NDS submission for Sativex in Canada

Read More

Treatment commences in Trinam phase II study

Read More

TransMID phase III program agreed under SPA

Read More

Positive results from RW study of SPI-0211 for constipation

Read More

TTP-889 successfully completes phase I

Read More

Hemispherx Biopharma to launch African trial of Alferon LDO for HIV

Read More

QR-435 shows therapeutic effect in influenza A animal studies

Read More

IND clearance for phase III trial of Rencarex in renal cell carcinoma

Read More

Preclinical efficacy of prostaglandin analogues AL-12180 and AL-12182

Read More

Selective IP antagonists inhibit bladder hyperreflexia in conscious rats and mice

Read More

Oral ECE inhibitor shows protective effect in rat model of bladder outlet obstruction

Read More

Testosterone gel associated with enhanced sexual function

Read More

Fumaric acid ester BG-12 effective in severe psoriasis

Read More

Etanercept in psoriasis subject of various presentations at EADV Spring Symposium

Read More

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing